- Filed
- Nov 16, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Nov 13, 2020 | 139.31M sh |
| Capex | Q1 2021 · Sep 30, 2020 | $352 |
| Cash And Equivalents | Q1 2021 · Sep 30, 2020 | $52.15K |
| Cash And Equivalents | Q1 2021 · Jun 30, 2020 | $119.96K |
| Total Liabilities | Q1 2021 · Sep 30, 2020 | $5.43M |
| Total Liabilities | Q1 2021 · Jun 30, 2020 | $4.84M |
| Current Assets | Q1 2021 · Sep 30, 2020 | $247.81K |
| Current Assets | Q1 2021 · Jun 30, 2020 | $367.3K |
| Total Assets | Q1 2021 · Sep 30, 2020 | $25.74M |
| Total Assets | Q1 2021 · Jun 30, 2020 | $25.35M |
| Operating Cash Flow | Q1 2021 · Sep 30, 2019 | $791.47K |
| Stockholders Equity | Q1 2021 · Sep 30, 2019 | $24.45M |
| Stockholders Equity | Q1 2021 · Jun 30, 2019 | $25.37M |
| Sga Expense restated | Q1 2021 · Sep 30, 2019 | $213.78K |
| Net Income | Q1 2021 · Sep 30, 2019 | −$150.1K |
| Operating Income | Q1 2021 · Sep 30, 2019 | −$149.76K |
| Revenue | Q1 2021 · Sep 30, 2019 | $172.18K |